Neoantigens and antibodies to factor VIII
- 1 June 1998
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 12 (2) , 99-105
- https://doi.org/10.1016/s0268-960x(98)90021-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Heating Lyophilised Factor VIII Does Not Alter Its Recognition by Specific AntibodiesVox Sanguinis, 1997
- Identification of Novel Factor VIII Inhibitor Epitopes using Synthetic Peptide ArraysVox Sanguinis, 1997
- GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERSHaemophilia, 1997
- Immune Tolerance for the Treatment of Factor VIII Inhibitors ‐ Twenty Years' ‘Bonn Protocol’Vox Sanguinis, 1996
- No Detectable Alterations in Immunogenicity following Terminal Severe Dry-Heat Treatment of High-Purity Factor VIII (Liberate) and Factor IX (HP9) ConcentratesVox Sanguinis, 1995
- Inhibitor development in haemophiliacsBlood Coagulation & Fibrinolysis, 1995
- Incidence of inhibitors in haemophiliacs. A review of the literatureBlood Coagulation & Fibrinolysis, 1993
- Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentratesAmerican Journal of Hematology, 1992
- High Molecular Weight Aggregate Content of Heated and Unheated Factor VIII Products Determined by Fast‐Protein Liquid ChromatographyVox Sanguinis, 1990
- Assessment of the antigenic response in humans to a recombinant mutant interferon betaJournal of Clinical Immunology, 1987